首页> 外文期刊>Current drug targets-The International journal for timely in-depth reviews on drug targets >Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology
【24h】

Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology

机译:与动脉粥样硬化相关的反式唾液酸酶:定义病理学中涉及的关键酶的身份

获取原文
获取原文并翻译 | 示例
           

摘要

Atherosclerosis is associated with the increased trans-sialidase activity, which can be detected in the blood plasma of atherosclerosis patients. The likely involvement in the disease pathogenesis made this activity an interesting research subject and the enzyme that may perform such activity was isolated and characterized in terms of substrate specificity and enzymatic properties. It was found that the enzyme has distinct optimum pH values, and its activity was enhanced by the presence of Ca2+ ions. Most importantly, the enzyme was able to cause atherogenic modification of low-density lipoprotein (LDL) particles in vitro. However, the identity of the discovered enzyme remained to be defined. Currently, sialyltransferases, mainly ST6Gal I, are regarded as major contributors to sialic acid metabolism in human blood. In this mini-review, we discuss the possibility that atherosclerosis-associated trans-sialidase does, in fact, belong to the sialyltransferases family.
机译:动脉粥样硬化与递增的反式唾液酸酶活性有关,可以在动脉粥样硬化患者的血液血浆中检测。 该疾病发病机制的可能涉及这项活性是有趣的研究受试者和可以在底物特异性和酶学性质方面进行分离和表征该活性的有趣研究受试者和酶。 发现酶具有不同的最佳pH值,其活性通过Ca 2 +离子的存在而增强。 最重要的是,酶能够在体外引起低密度脂蛋白(LDL)颗粒的动脉发生修饰。 然而,仍然定义发现的酶的身份。 目前,Sialyl转移酶主要是ST6GAL I,被认为是人类血液中唾液酸代谢的主要贡献者。 在这种迷你审查中,我们讨论了动脉粥样硬化相关的反式唾液酸酶的可能性实际上属于唾液酸甲酰胺酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号